Trial intelligence / Profile preview

Ortho-R for Rotator Cuff Repair

NCT05333211Phase 2Unknown

Sponsor
ChitogenX Inc.
Start
Jul 2022
Primary completion
Dec 2023
Modality
Implantable Devices, Implantable Hydrogels
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rotator cuff tear comparing Investigational Arm with Ortho-R/PRP with Control Arm Standard of Care (2 arms). Primary endpoints: Complications at 12 months and Incidence of cuff re-tears at 12 months. Status: unknown.

02

Drugs

ORTHO-R
03

Conditions

rotator cuff tear

Beyond the preview

Go deeper on NCT05333211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05333211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call